References
- Krebs HA. Metabolism of amino-acids: the synthesis of glutamine from glutamic acid and ammonia, and the enzymic hydrolysis of glutamine in animal tissues. Biochem J. 1935;29(8):1951–69.
- Rose CF, Verkhratsky A, Parpura V. Astrocyte glutamine synthetase: pivotal in health and disease. Biochem Soc Trans. 2013;41(6):1518–24. doi:https://doi.org/10.1042/BST20130237.
- Navazio F, Gerritsen T, Wright GJ. Relationship of ammonia intoxication to convulsions and coma in rats. J Neurochem. 1961;8:146–51. doi: https://doi.org/10.1111/j.1471-4159.1961.tb13536.x
- Spodenkiewicz M, Diez-Fernandez C, Rufenacht V, Gemperle-Britschgi C, Haberle J. Minireview on glutamine synthetase deficiency, an ultra-rare inborn error of amino acid biosynthesis. Biology (Basel). 2016;5(4). doi:https://doi.org/10.3390/biology5040040.
- Haberle J, Shahbeck N, Ibrahim K, Schmitt B, Scheer I, O’Gorman R, et al. Glutamine supplementation in a child with inherited GS deficiency improves the clinical status and partially corrects the peripheral and central amino acid imbalance. Orphanet J Rare Dis. 2012;7:48. doi:https://doi.org/10.1186/1750-1172-7-48.
- Eid T, Thomas MJ, Spencer DD, Runden-Pran E, Lai JC, Malthankar GV, et al. Loss of glutamine synthetase in the human epileptogenic hippocampus: possible mechanism for raised extracellular glutamate in mesial temporal lobe epilepsy. Lancet. 2004;363(9402):28–37. doi: https://doi.org/10.1016/S0140-6736(03)15166-5
- Steffens M, Huppertz HJ, Zentner J, Chauzit E, Feuerstein TJ. Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: implications for the pathophysiology of epilepsy. Neurochem Int. 2005;47(6):379–84. doi:https://doi.org/10.1016/j.neuint.2005.06.001.
- Rosati A, Marconi S, Pollo B, Tomassini A, Lovato L, Maderna E, et al. Epilepsy in glioblastoma multiforme: correlation with glutamine synthetase levels. J Neuro-Oncol. 2009;93(3):319–24. Epub 2009/02/03. doi:https://doi.org/10.1007/s11060-008-9794-z.
- Eid T, Ghosh A, Wang Y, Beckstrom H, Zaveri HP, Lee TS, et al. Recurrent seizures and brain pathology after inhibition of glutamine synthetase in the hippocampus in rats. Brain. 2008;131(8):2061–70. doi:https://doi.org/10.1093/brain/awn133.
- Zhou Y, Hassel B, Eid T, Danbolt NC. Axon-terminals expressing EAAT2 (GLT-1; Slc1a2) are common in the forebrain and not limited to the hippocampus. Neurochem Int. 2018. doi:https://doi.org/10.1016/j.neuint.2018.03.006.
- Albright B, Dhaher R, Wang H, Harb R, Lee TW, Zaveri H, et al. Progressive neuronal activation accompanies epileptogenesis caused by hippocampal glutamine synthetase inhibition. Exp Neurol. 2017;288:122–33. doi:https://doi.org/10.1016/j.expneurol.2016.10.007.
- Racine RJ, Burnham WM, Gartner JG, Levitan D. Rates of motor seizure development in rats subjected to electrical brain stimulation: strain and inter-stimulation interval effects. Electroencephalogr Clin Neurophysiol. 1973;35(5):553–6. doi: https://doi.org/10.1016/0013-4694(73)90033-3
- Dhaher R, Damisah EC, Wang H, Gruenbaum S, Ong C, Zaveri HP, et al. 5-aminovaleric acid suppresses the development of severe seizures in the methionine sulfoximine model of mesial temporal lobe epilepsy. Neurobiol Dis. 2014;67:18–23. doi:https://doi.org/10.1016/j.nbd.2014.03.006.
- Dhaher R, Wang H, Gruenbaum SE, Tu N, Lee TS, Zaveri HP, et al. Effects of site-specific infusions of methionine sulfoximine on the temporal progression of seizures in a rat model of mesial temporal lobe epilepsy. Epilepsy Res. 2015;115:45–54. doi:https://doi.org/10.1016/j.eplepsyres.2015.05.005.
- Curthoys NP, Watford M. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr. 1995;15:133–59. doi:https://doi.org/10.1146/annurev.nu.15.070195.001025.
- Bagga P, Behar KL, Mason GF, De Feyter HM, Rothman DL, Patel AB. Characterization of cerebral glutamine uptake from blood in the mouse brain: implications for metabolic modeling of 13C NMR data. J Cereb Blood Flow Metab. 2014;34(10):1666–72. doi:https://doi.org/10.1038/jcbfm.2014.129.
- Albrecht J, Norenberg MD. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology. 2006;44(4):788–94. doi: https://doi.org/10.1002/hep.21357
- Hawkins RA, O’Kane RL, Simpson IA, Vina JR. Structure of the blood-brain barrier and its role in the transport of amino acids. J Nutr. 2006;136(Suppl. 1):218S–26S. doi:https://doi.org/10.1093/jn/136.1.218S.
- Schousboe A, Waagepetersen HS. Role of astrocytes in homeostasis of glutamate and GABA during physiological and pathophysiological conditions. Adv Mol Cell Biol. 2003;31:461–74. doi: https://doi.org/10.1016/S1569-2558(03)31020-3
- Attwell D, Laughlin SB. An energy budget for signaling in the grey matter of the brain. J Cereb Blood Flow Metab. 2001;21(10):1133–45. Epub 2001/10/13. doi:https://doi.org/10.1097/00004647-200110000-00001.
- de Souza AZ, Zambom AZ, Abboud KY, Reis SK, Tannihao F, Guadagnini D, et al. Oral supplementation with L-glutamine alters gut microbiota of obese and overweight adults: a pilot study. Nutrition. 2015;31(6):884–9. Epub 2015/05/03. doi:https://doi.org/10.1016/j.nut.2015.01.004.
- Olson CA, Vuong HE, Yano JM, Liang QY, Nusbaum DJ, Hsiao EY. The gut microbiota mediates the anti-seizure effects of the ketogenic diet. Cell. 2018;173(7):1728–41.e13. Epub 2018/05/29. doi:https://doi.org/10.1016/j.cell.2018.04.027.
- Kanamori K, Ross BD. Chronic electrographic seizure reduces glutamine and elevates glutamate in the extracellular fluid of rat brain. Brain Res. 2011;1371:180–91. doi:https://doi.org/10.1016/j.brainres.2010.11.064.
- Kanamori K, Ross BD. Electrographic seizures are significantly reduced by in vivo inhibition of neuronal uptake of extracellular glutamine in rat hippocampus. Epilepsy Res. 2013;107(1–2):20–36. doi:https://doi.org/10.1016/j.eplepsyres.2013.08.007.
- Wang H, Huang Y, Coman D, Munbodh R, Dhaher R, Zaveri HP, et al. Network evolution in mesial temporal lobe epilepsy revealed by diffusion tensor imaging. Epilepsia. 2017;58(5):824–34. Epub 2017/04/06. doi:https://doi.org/10.1111/epi.13731.
- D’Andrea Meira I, Romão TT, Pires do Prado HJ, Krüger LT, Pires MEP, da Conceição PO. Ketogenic diet and epilepsy: what we know so far. Front Neurosci. 2019;13:5. doi:https://doi.org/10.3389/fnins.2019.00005.
- Rogawski MA. A fatty acid in the MCT ketogenic diet for epilepsy treatment blocks AMPA receptors. Brain. 2016;139(2):306–9. Epub 2016/02/26. doi:https://doi.org/10.1093/brain/awv369.